HealthProblem 0005
Resistance is as much a data problem as a drug problem. Surveillance depends on cultures, and much of the world's prescribing happens where there is no microbiology laboratory within reach, so the clinician makes a reasonable guess, and what happens next is rarely recorded anywhere that would improve the next one. The map of what still works is drawn from the minority of cases that reach a lab.
Who lives with itPrescribers in primary and rural care · national AMR programmes · hospital pharmacy and stewardship teams
Why nowThe WHO's 2025 global surveillance report draws on more than 23 million confirmed cases reported by 104 countries across 93 combinations of infection type, pathogen and antibiotic: the most complete picture yet assembled, and still one built from where testing exists rather than where prescribing happens.
Why it matters · the JudgeThe feedback loop that would slow resistance is broken at its cheapest point: capture. Anything that makes empirical prescribing legible without requiring a laboratory improves the map for everyone, and most of what is sold here is tests rather than information.
Inspired by reporting from World Health Organization
